Ascend Wellness Holdings (AAWH) Total Current Liabilities (2020 - 2026)

Ascend Wellness Holdings' (AAWH) quarterly Total Current Liabilities came in at $88.5 million in Q1 2026, down 40.2% year-on-year from $147.9 million in Q1 2025, and down 18.85% quarter-over-quarter from $109.0 million in Q4 2025.

Ascend Wellness Holdings (AAWH) Total Current Liabilities (2020 - 2026) Analysis & Trends

Ascend Wellness Holdings' Total Current Liabilities history runs 7 years deep, the most recent figure standing at $88.5 million for Q1 2026.

  • On a quarterly basis, Total Current Liabilities fell 40.2% year-over-year to $88.5 million in Q1 2026; TTM through Mar 2026 was $88.5 million, a 40.2% decrease from a year earlier, with the FY2025 full-year figure at $109.0 million, down 24.58% from the prior year.
  • Total Current Liabilities slipped to $88.5 million in Q1 2026 per AAWH's latest filing, from $109.0 million in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $147.9 million in Q1 2025 and bottomed at $88.5 million in Q1 2026.
  • The 5-year median for Total Current Liabilities is $109.8 million (2023), against an average of $116.2 million.
  • Across the five-year window, Total Current Liabilities jumped 55.95% in 2024 and plunged 40.2% in 2026, its largest moves.
  • Year by year, Total Current Liabilities stood at $110.9 million in 2022, then slipped by 16.46% to $92.7 million in 2023, then soared by 55.95% to $144.5 million in 2024, then decreased by 24.58% to $109.0 million in 2025, then decreased by 18.85% to $88.5 million in 2026.
  • Per Business Quant, the three latest AAWH Total Current Liabilities figures stand at $88.5 million (Q1 2026), $109.0 million (Q4 2025), and $96.0 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 6.56 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 13.53 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 2.05 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 18.06 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 599.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - 13.17 Bn
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 6.81 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 831.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 1.66 Bn
10 Ascend Wellness Holdings 83.00 Mn 22.91 Mn 44.88 Mn 88.46 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 88.46 Mn
Dec 31, 2025 109.01 Mn
Sep 30, 2025 96.00 Mn
Jun 30, 2025 100.79 Mn
Mar 31, 2025 147.92 Mn
Dec 31, 2024 144.54 Mn
Sep 30, 2024 145.13 Mn
Jun 30, 2024 103.06 Mn
Mar 31, 2024 103.44 Mn
Dec 31, 2023 92.69 Mn
Sep 30, 2023 129.76 Mn
Jun 30, 2023 124.65 Mn
Mar 31, 2023 109.81 Mn
Dec 31, 2022 110.95 Mn
Sep 30, 2022 137.50 Mn
Jun 30, 2022 122.04 Mn
Mar 31, 2022 109.33 Mn
Dec 31, 2021 117.40 Mn
Sep 30, 2021 104.89 Mn
Jun 30, 2021 110.22 Mn